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Traditionally, medicine has held that some human body sites are sterile and that the
introduction of microbes to these sites results in infections. This paradigm shifted
significantly with the discovery of the human microbiome and acceptance of these
commensal microbes living across the body. However, the central nervous system
(CNS) is still believed by many to be sterile in healthy people. Using culture-independent
methods, we examined the virome of cerebrospinal fluid (CSF) from a cohort of mostly
healthy human subjects. We identified a community of DNA viruses, most of which
were identified as bacteriophages. Compared to other human specimen types, CSF
viromes were not ecologically distinct. There was a high alpha diversity cluster that
included feces, saliva, and urine, and a low alpha diversity cluster that included CSF,
body fluids, plasma, and breast milk. The high diversity cluster included specimens
known to have many bacteria, while other specimens traditionally assumed to be sterile
formed the low diversity cluster. There was an abundance of viruses shared among CSF,
breast milk, plasma, and body fluids, while each generally shared less with urine, feces,
and saliva. These shared viruses ranged across different virus families, indicating that
similarities between these viromes represent more than just a single shared virus family.
By identifying a virome in the CSF of mostly healthy individuals, it is now less likely that
any human body site is devoid of microbes, which further highlights the need to decipher
the role that viral communities may play in human health.
Keywords: human microbiome, virome, virobiota, CSF, microbiota, body fluids, cerebral spinal fluid,
cerebrospinal fluid
INTRODUCTION
For some time, many body surfaces were believed to be inhabited by few if any microorganisms
and the exposure to bacteria, viruses, and other pathogens generally resulted in potentially
life-threatening infections. The development of modern cultivation techniques (Emerson
and Wilson, 2009; Stewart, 2012) and next-generation sequencing technologies (Goodwin
et al., 2016; Cao et al., 2017) has revealed that these body surfaces are inhabited by a
much broader array of microorganisms. These microbes collectively are referred to as the
human microbiome. They are involved in important metabolic and physiological processes
(Turnbaugh et al., 2009; Qin et al., 2010; Burke et al., 2011; Human Microbiome Project
Consortium, 2012; Ursell et al., 2012), and are increasingly recognized for their role in
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human health (Fujimura et al., 2010; Willing et al., 2010; Relman,
2012; Arrieta et al., 2015). There is increasing recognition of
microbes associated with the mouth, gut, skin, vagina, bladder,
and lungs (Costello et al., 2009; Human Microbiome Project
Consortium, 2012; Cui et al., 2014), but in other regions of the
body such as the blood, and central nervous system (CNS), the
presence of a microbiome is not widely recognized or accepted.
Much of the human microbiome research is focused on
the bacterial component, yet a growing body of work is
demonstrating the ubiquity of viral communities across the body.
Studies have shown the presence of viral communities in saliva
and dental plaque (Abeles et al., 2014; Ly et al., 2014), lower
gastrointestinal (GI) tract (Reyes et al., 2010; Columpsi et al.,
2016; Thannesberger et al., 2017), respiratory tract (Wylie, 2017),
skin (Hannigan et al., 2015), bladder (Santiago-Rodriguez et al.,
2015a), vagina (Wylie et al., 2014, 2018), bloodstream (Sauvage
et al., 2016; Moustafa et al., 2017), and breast milk (Pannaraj et al.,
2018). The abundance of viruses found across the body suggests
that there may be no body surfaces that are truly devoid of viruses;
thus, no body surface may be truly sterile.
The majority of the viruses found on human body surfaces
may be bacterial viruses known as bacteriophages. On some of
these surfaces, bacteriophages (phages for short) are persistent
and ubiquitous, with some able to persist months and perhaps
years (Minot et al., 2011; Abeles et al., 2014; Ly et al.,
2016). Members of phage communities can be shared with
unrelated housemates (Robles-Sikisaka et al., 2013; Ly et al.,
2016), suggesting that they may not just affect the bacteria
on your body surfaces, but that they may affect the bacterial
communities of people you live with as well. The ecology of
phage communities appears to be specific for certain body sites.
For example, the phage communities of GI tract are unique
from those found in the mouth (Abeles et al., 2015). Further
site-specific features have been observed in the oral cavity with
salivary phages differing significantly from those found within
dental plaque (Ly et al., 2014). In certain disease conditions,
including periodontal disease (Ly et al., 2014) and ulcerative
colitis (Norman et al., 2015), phage communities are associated
with the disease condition. Yet whether these phages play a role
in disease development or maintenance is not yet known.
In fact, we know very little about the role and function
of viromes across the human body. Due to their abundance,
phages have been hypothesized to shape bacterial communities
by killing their hosts (Edlund et al., 2015). Bacteriophages
may provide non-host-derived immunity by binding to human
mucosal layers, regulating mucosal bacterial communities via
subdiffusive motion, which increases their probability to contact
with a bacterial host (Barr et al., 2013, 2015). Recently, phages
were demonstrated to transcytose across in vitro epithelial
barriers (Nguyen et al., 2017). Bacteriophage transcytosis from
the gut may provide a mechanism for phages to directly access
the internalized body sites not previously known to harbor
viral communities.
In this study, we sought to evaluate whether the traditionally
“sterile” CNS in humans contains a stable virome. We obtained
cerebrospinal fluid (CSF) from a cohort of 20 subjects with and
without infections, and contrasted these with viromes obtained
from a number of different body sites. Our goals were to: (1)
demonstrate the presence of a virome unique to the CNS, (2)
identify whether viruses found in CSF are similar to those found
on other body surfaces, and (3) identify ecological trends in
CSF viromes and compare with ecological trends observed on
other body surfaces.
MATERIALS AND METHODS
Human Subjects and Culture Conditions
Human subject involvement in this study was approved by the
University of California, San Diego Administrative Panel on
Human Subjects in Medical Research. The study was certified
as category 4 exempt, which does not require informed consent
on behalf of the study subjects. The research was categorized as
exempt because it involved the collection or study of existing
data, documents, records, pathological specimens, or diagnostic
specimens that were recorded in such a manner that the subjects
could not be identified, directly or through identifiers linked to
the subjects. We sampled CSF from 20 human subjects, body
fluids from 5 subjects, and plasma (the supernatant collected
after spinning whole blood centrifuged for 15 min that was
collected in EDTA-treated lavender top tubes) from 10 subjects
(Supplementary Table S1). Each of the CSF, plasma, and body
fluid specimens was stored at 4◦C, and processed within 7 days of
their collection.
CSF specimens were collected under sterile conditions using
standard protocols (Teunissen et al., 2009). Briefly, skin was
sterilized with povidone-iodine and allowed to dry. The lumbar
area was draped to create a sterile field, and a 22 gauge needle
was inserted between the L3 and L5 vertebral bodies until CSF
began to flow. The first few drops were discarded, and 4 separate
tubes of CSF were collected. Approximately 2–4 mL of CSF was
collected into each tube consecutively from Tube#1 to Tube#4.
The CSF that was collected in Tube#3 was used for standard
of care cultures, and then was used for virome analysis in this
study. Tubes#1 and #4 were used for cell counts, and counts from
Tube#4 are reported in this study (Supplementary Table S1).
Standard of care procedures for CSF collection were followed for
all subjects enrolled in the study. Because this study was certified
as category 4 exempt, the study team could not be involved in the
CSF collection process.
Assessing the CSF and Body Fluids for
Bacteria
In an effort to verify that CSF specimens were relatively devoid
of bacteria, we analyzed the CSF specimens for the presence
of 16S rRNA. DNA was extracted from CSF using the Qiagen
DNeasy Powersoil kit (Qiagen) and further concentrated using
the Zymo gDNA Clean and Concentrate kit (Zymo). Purified
and concentrated DNA was subjected to PCR using Kapa Hifi
Hotstart Readymix (Kapa Biosystems) and PCR forward primer
5′-TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG
CCT ACG GGN GGC WGC AG-3′ and reverse primer 5′-GTC
TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GGA
CTA CHV GGG TAT CTA ATC C-3′ to amplify the V3–V4
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hypervariable segment of 16S rRNA. We used the following
cycling parameters: 95◦C for 3 min, followed by 35 cycles of 95◦C
for 30 s, 55◦C for 30 s, 72◦C for 30 s, and a final elongation step of
72◦C for 5 min. Amplicons were purified with Ampure XP beads
(Beckman-Coulter) and visualized using a High Sensitivity DNA
Kit on a Bioanalyzer (Agilent Technologies). No amplification
products could be visualized from CSF specimens from subjects
not already known to be infected with bacteria.
Virome Preparation and Sequencing
CSF and body fluid specimens were treated in an identical
manner as we have developed for processing of saliva specimens
(Abeles et al., 2014). To determine the counts of virus-like
particles in CSF and body fluids, we modified an existing
procedure commonly used to isolate viruses from environmental
samples (Thurber et al., 2009). Samples were filtered sequentially
using 0.45 and 0.2µm cellulose acetate filters (GE Healthcare Life
Sciences) to remove cellular and other debris. A 10 µL aliquot
of the filtered CSF or body fluid was resuspended in 190 µL of
0.02 µm filtered PBS, and was then filtered through a 0.02 µm
filter to trap the virus particles. They were then stained using
SYBR-gold and visualized by epifluorescence microscopy (Noble
and Fuhrman, 1998). The concentration of the virus-like particles
was estimated based on the mean number of particles from at
least four separate high-power fields.
To purify the CSF and body fluid viromes, the samples
were filtered sequentially using 0.45 and 0.2 µm cellulose
acetate filters (GE Healthcare Life Sciences) to remove cellular
and other debris (Pride et al., 2012). CSF and body fluid
specimens were then purified on a cesium chloride gradient
according to our previously described protocols (Pride et al.,
2012). Only the fraction with a density corresponding to most
known bacteriophages (Murphy et al., 1995) was retained,
further purified on Amicon YM-100 protein purification
columns (Millipore, Inc.), treated with 2 units of DNase I,
and subjected to lysis and DNA purification using the Qiagen
UltraSens Virus kit (Qiagen). Recovered DNA was screened
for the presence of contaminating bacterial nucleic acids by
the protocol described above. Viral DNA then was amplified
using GenomiPhi Hy MDA amplification (GE Healthcare Life
Sciences), and specimens prepared for sequencing using the
Nextera DNA Library Prep XT kit (Illumina, Inc.) according to
manufacturer instructions. We included sterile water that had
gone through the virome extraction process as negative controls
for the MDA amplification, and were able to produce amplified
products from the sterile water. Those specimens were further
processed identically to the other virome specimens. The size
of amplified virome products was determined using a High
Sensitivity DNA Kit on a Bioanalyzer (Agilent Technologies),
and quantified using a High Sensitivity Double Stranded DNA
kit on a Qubit Fluorometer (Thermo Fisher Scientific). DNA
from each specimen was pooled into equimolar proportions
and sequenced on the Illumina MiniSeq Instrument (Illumina,
Inc.). We trimmed sequence reads according to Phred scores
of 30, removed any low complexity reads with ≥8 consecutive
homopolymers, and removed any reads with substantial length
variation (<50 nucleotides or >300 nucleotides) or ambiguous
characters prior to further analysis. Each virome was screened
for contaminating nucleic acids using BLASTN analysis (E-
score < 10−5) against the human reference database available at
ftp://ftp.ncbi.nlm.nih.gov/genomes/H_sapiens/. Any reads with
significant sequence similarities to human sequences were
removed prior to further analysis using Ion Assist1. We also
screened the virome reads for potential bacterial contamination
by mapping reads with low stringency (80% similarity across
20% of the read length) against the database of bacterial
genomes2 using CLC Genomics Workbench 9.5.3 (Qiagen).
For any virome where >10% of the reads mapped to bacteria
genomes, we manually examined the read mapping patterns.
When viromes mapped across much of the bacteria genome, they
were considered contaminated and were removed from the study
even if bacteria were not detected by 16S rRNA amplification.
Virome Analysis
All reads were assembled using CLC Genomics Workbench
9.5.3 (Qiagen) based on 98% identity with a minimum of 50%
read overlap, which were more stringent than those developed
to discriminate between highly related viruses (Breitbart et al.,
2002). Because the average and median read lengths were 150
nucleotides, the minimum tolerable overlap was approximately
75 nucleotides (Supplementary Table S2). We also constructed
contigs based on 98% identify with a minimum of 80% read
overlap. Because the constructed contigs were highly similar
to those constructed with a minimum of 50% read overlap
(Supplementary Table S3), we used those constructed at 50%
read overlap to be consistent with our prior studies. The
consensus sequence for each contig was constructed according
to majority rule and any contigs <200 nucleotides were removed
prior to further analysis.
Virome contigs were annotated using BLASTX against the
NCBI NR database with an E-value cutoff value of 10−5. Specific
viral sequences were identified using Ion Assist3 by parsing
BLASTX results for known viral genes including replication,
structural, transposition, restriction/modification, hypothetical,
and other genes previously found in viruses for which the E-
value was at least 10−5. Each individual virome contig was
annotated using this technique, however, if the best hit for any
portion of the contig was to a gene with no known function,
lower level hits were used as long as they had known function
and still met the E-value cutoff. These BLASTX hits were
used for comparisons of gene functions in viruses, but not
for taxonomic analysis. ORF prediction was performed using
FGenesV (Softberry Inc., Mount Kisco, NY, United States), and
putative functions assigned by BLASTP homology against the
NR database (Escore < 10−5). Virus types were determined by
parsing the virus families from the TBLASTX best hits of each
viral contig with an E-value < 10−20 (Pannaraj et al., 2018). We
also identified virome contigs with significant homologs in the
IMG/VR v2.0 database (Paez-Espino et al., 2019) using BLASTX
with an E-value cutoff value of 10−5.
1www.thepridelaboratory.org
2ftp://ftp.ncbi.nlm.nih.gov/genomes/genbank/bacteria/
3www.thepridelaboratory.org
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We constructed assemblies from the CSF contigs of all
subjects combined using 98% identity across 50% of the read
lengths to determine viruses that might be present in multiple
different subjects. We then characterized the resulting assemblies
to determine which subjects contributed to the construction of
these larger viruses and the relative coverage of each contig
from each subject. We characterized these larger viral assemblies
using BLASTX analysis (E-value cutoff 10−5) against the NR
database. Resulting virus structures were determined for ORF
structures and directionality using MetaGeneMark (Zhu et al.,
2010). ORFs were annotated on each contig with Geneious v.
11.1.5 (Kearse et al., 2012).
Analysis of shared sequence similarities present in each
virome was performed by creating custom BLAST databases
for each virome, comparing each database with all other
viromes using BLASTN analysis (E-value < 10−10), and these
compiled data used to calculate beta diversity with Bray Curtis
distances using QIIME (Caporaso et al., 2010). These distances
were used as input for PCoA. Statistical tests were performed
using the Adonis function in the R Vegan package with 999
permutations (Oksanen et al., 2010). We determined putative
sharing of homologous viruses by constructing assemblies from
all specimen types, and then deciphered the contribution to
each resulting contig, similar to techniques we have previously
described (Abeles et al., 2014; Ly et al., 2016). We utilized this
technique to decipher those contigs that were unique to each
specimen type, and those shared between different specimen
types. Statistical significance was determined by comparisons
between groups by the Mann–Whitney U-test using SPSS 25
(IBM). We also performed a permutation test (10,000 iterations)
to assess whether viromes from different specimen types had
significant overlap using Ion Assist4 (Robles-Sikisaka et al., 2013).
Included among these specimens that we examined from prior
studies was saliva from 8 subjects, feces from 9 subjects, urine
from 20 subjects, and breast milk from 10 subjects (Robles-
Sikisaka et al., 2013; Abeles et al., 2014; Ly et al., 2014; Naidu
et al., 2014; Robles-Sikisaka et al., 2014). We simulated the
distribution of the fraction of shared virome homologs between
all specimen types. For each specimen type, we computed the
summed fraction of shared homologs using 1000 random contigs
between randomly chosen between specimen types, and from
these computed an empirical null distribution of our statistic
of interest (the fraction of shared homologs). The simulated
statistics within each specimen type was referred to the null
distribution of inter-specimen type comparisons, and the p-value
was computed as the fraction of times the simulated statistic for
the each exceeded the observed statistic.
Viral Diversity
To measure alpha diversity in the viral communities, we utilized
a technique termed the Homologous Virus Diversity Index
(HVDI). The technique is based on finding high levels of
homology amongst contigs within viromes that likely belong to
the same virus but were placed into separate contigs due to the
limitations of the assembly process (Abeles et al., 2014). Virome
4www.thepridelaboratory.org
reads were assembled using 98% identify over a minimum
of 50% of the read length using CLC Genomics Workbench
9.5.3 (Qiagen), and the resulting contig spectra utilized as the
primary input for the index. We did not use any contig length
cutoff for our analysis of alpha diversity because the metrics
for determining alpha diversity are highly dependent on the
number of singletons (reads that did not assemble) in their
estimates of diversity. We created custom nucleotide BLAST
databases for each specimen type that contained all contigs. We
then used BLASTN analysis to find high levels of homology
(e-score < 10−20) between different contigs within the same
specimen type. We accepted only high levels of homology
that spanned at least 50% of the length of the shorter contig
being compared, which would be a minimum length of 75 bp.
All contigs in each specimen type were treated as nodes and
those contigs that had high homology to other contigs in the
same specimen type were added to a network by directing
edges between the nodes. After evaluating homologies among
all intra-specimen type contigs, networks formed from directed
edges/nodes were assigned to individual viruses and nodes
with no associations were considered singular viruses. For each
resulting network, we added the number of reads assigned to each
node on the network and the combined number of reads was
used to represent the relative abundance of the virus represented
by that network. The relative abundances of all viruses were
calculated using this technique, and a new contig spectrum
representing the viral population in each specimen type was
formed. The contig spectrum from each specimen type then was
used as a surrogate for population structures and input directly
into the chao1 index (Chao, 1984) to estimate diversity.
RESULTS
Human Subject Characteristics
We received approval from our Human Subjects Protections
Program to obtain residual CSF specimens from a cohort
of 20 subjects who had undergone lumbar punctures within
the prior 72 h. Of those 20 individuals, four subjects were
diagnosed with CNS infections based on their CSF white blood
cell counts and the recovery of pathogens (Supplementary
Table S1). We also obtained residual specimens from other
specimen types, including blood plasma from 10 human subjects,
and miscellaneous body fluids from another five subjects
(Supplementary Table S1). These specimens were also collected
within the prior 72 h. Of those five miscellaneous body fluid
samples, three specimens were peritoneal fluid, one was hip
fluid, and one sample was bile. The biliary fluid specimen was
collected from a drainage tube in an individual with cholangitis
(an infection of the bile duct), while the other body fluid
specimens were clinically sterile (no growth on standard culture
media) (Supplementary Table S1).
Processing of CSF and Body Fluid
Viromes
We performed epifluorescence microscopy on CSF specimens
to identify the presence of virus-like particles (VLPs) prior to
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virome processing. We found an average of 104 VLPs per mL of
CSF in the cohort (Supplementary Figure S1A), compared with
non-sterile saliva samples from another cohort, which contained
to 106 VLPs (Supplementary Figure S1B). These data indicate
that there were VLPs present within the CSF, but at many orders
of magnitude less than a traditionally non-sterile site. We next
processed the DNA viromes isolated from CSF, plasma, and other
body fluids according to our previously described protocol for
virome preparations from saliva (Abeles et al., 2014). Briefly,
samples were sequentially filtered, purified via cesium chloride
density gradient centrifugation, followed by lysis of virions,
extraction of nucleic acids, and next-generation sequencing. We
also processed viromes from sterile water to help determine
whether viromes could be contaminated from viruses that are
observed in the water used in the experiments. From the 20
CSF specimens, we sequenced 41,102,484 reads of mean length
150 nucleotides for an average of 2,055,124 reads per subject;
for the 10 plasma specimens, we sequenced 10,694,439 reads of
mean length 150 nucleotides for an average of 1,069,439 reads per
subject; for the 5 body fluid specimens, we sequenced 5,594,438
reads of mean length 150 nucleotides for an average of 1,118,888
reads per subject (Supplementary Table S2). We extracted DNA
from a subset of 10 CSF specimens without clinical infections to
amplify and sequence the V3–4 segment of 16S rRNA, but no
amplicons could be obtained when measured on a bioanalyzer.
Our inability to amplify 16S rRNA from CSF specimens suggests
that they were relatively devoid of bacteria.
We assembled virome reads from each subject and specimen
type to build larger viral contigs because their greater length
leads to more productive searches for homologous sequences
in available databases (Pride et al., 2012). We obtained a mean
of 273 ± 25 contigs per CSF specimen, 143 ± 33 contigs per
body fluid specimen, 220 ± 25 contigs per plasma specimen
(Supplementary Table S2), and 162 ± 25 for water controls
(Supplementary Figure S2). Most of the CSF reads assembled
into contigs that had homology to viruses (70.6 ± 4.6%),
bacteria (15.6 ± 3.1%); seen commonly when lysogenic phages
are found in viromes (Pride et al., 2012), or had no known
homologies (13.8 ± 3.6%; Supplementary Figure S3). Plasma
reads assembled into contigs with 78.8 ± 5.9% homologous
to known viruses, 18.6 ± 5.9% homologous to bacteria, and
11.2 ± 3.5% with no known homologs. Body fluid reads
assembled into contigs with 60.8 ± 4.9% homologous to known
viruses, 12.0 ± 3.4% homologous to bacteria, and 27.3 ± 6.0%
with no known homologs. From the sterile water, we also were
able to identify 21% with homology to known viruses, none with
homology to bacteria, and 79.2% with no known homologies. Of
those 20.8% with homologs to viruses, 19.2% were homologous
to an E. coli Lambda phage that was not also identified in
CSF specimens. These findings combined reveal substantial virus
populations in CSF, body fluids, and plasma.
We also examined the CSF viromes using the IMG/VR v2.0
database (Paez-Espino et al., 2019). The IMG/VR v2.0 database
is currently the largest available dataset available for virome
analysis, and includes cultivated viruses, curated prophages,
and computationally predicted viruses from metagenomes. We
found that 68.3 ± 0.7% of the CSF viromes had homologs
in this database (Supplementary Figure S4) with median
E-score values ranging from 3−27 to 6−38, which was similar
to what we observed with the NR database (Supplementary
Figure S3). Many of the viral contigs (70.3 ± 1.1%) from body
fluids were also homologous to virus metagenome fragments
(Supplementary Figure S4). We also characterized the habitats
from which these homologs were derived (Supplementary
Figure S5). A large proportion of them were homologous to
curated prophages (16.5%), human associated viromes (15.7%),
aquatic viromes (24.4%), plant viromes (13.4%), and viromes
from the built environment (9.51%) (Supplementary Table S4).
Of those human associated viromes, 7.8% were homologous
to fecal viromes and 6.7% were homologous to oral viromes.
Only a small percentage (0.8%) had homologs identified in
viromes from the skin.
Beta Diversity in CSF and Body Fluid
Viromes
We characterized the beta diversity in the viromes of CSF
and body fluids using Bray Curtis distances, tested the
significance with Adonis, and visualized the output using PCoA
analysis. While significant (p < 0.05, R2 = 0.07) only a
small percentage of the variation could be explained by the
sample type (Supplementary Figure S6). We next analyzed the
beta diversity amongst the CSF specimens to identify whether
there may be distinguishing features between those individuals
with infections compared to those without. While we only
characterized specimens from 4 individuals with CNS infections
(Supplementary Table S1), there were no trends in beta diversity
that distinguished these specimens (data not shown). These
findings suggest that infection status may not be a characteristic
that defines CSF viral ecology, but a larger sample size is necessary
to confirm this finding.
Taxonomic Analysis of Viruses in CSF,
Body Fluids, and Other Human Specimen
Types
We next characterized the putative taxonomic compositions of
the CSF and body fluid viromes to determine whether these
viromes were populated by different families of viruses. Most
of the contigs (93.4 ± 0.3% for CSF and 89.4 ± 2.3% for body
fluids) could not be assigned to viral families (Supplementary
Figure S7). Of those contigs that could be assigned, the vast
majority were bacteriophages in body fluids (96.3 ± 2.5%) and
CSF (83.1 ± 5.1%), while fewer eukaryotic virus families were
identified in each sample type. The majority of the bacteriophages
identified were Caudovirus families Myoviridae (generally larger
dsDNA genomes with contractile tails), Siphoviridae (mid-sized
dsDNA genomes with non-contractile tails), and Podoviridae
(smaller dsDNA genomes with short tail stubs) (Supplementary
Figure S8). Many but not all siphoviruses have primarily
lysogenic lifestyles, while myoviruses and podoviruses often
have lytic lifestyles (Wichels et al., 1998; Sullivan et al., 2003).
Phages from the ssDNA family Inoviridae and other dsDNA
phages that could not be further classified were also identified.
Amongst the eukaryotic viruses identified were Phycodnaviridae,
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Herpesviridae, and Mimiviridae. We failed to identify differences
in the CSF that might delineate the infected from the uninfected
individuals. These data suggest that many different virus families
inhabit CSF and body fluids, with bacteriophages representing
the preponderance of the community.
To delineate whether taxonomic trends seen in CSF and body
fluid viromes may be similar to those from other human body
sites, we compared data from previously sequenced viromes from
feces (Abeles et al., 2015), saliva (Abeles et al., 2014), urine
(Santiago-Rodriguez et al., 2015a), and breast milk (Pannaraj
et al., 2018) in our prior studies. There were some features
that delineated many specimen types (Figure 1). In feces, there
was an abundance of microviruses; in saliva there were high
levels of siphoviruses; in urine, there were papillomaviruses and
herpesviruses; in breast milk, there were substantial numbers
of myoviruses; in body fluids, there were many viruses from
the phage family Inoviridae. There were no obvious taxonomic
distinguishing features of CSF or plasma viromes that could not
be identified in the other specimen types.
Diversity Amongst CSF and Other
Specimen Types
We next examined beta and alpha diversity in the viromes of each
specimen type. We visualized beta diversity using PCoA analysis
and tested whether there were significant differences among the
sample types with Adonis (Figure 2). The viral communities were
distinct based on sample type (p < 0.001, R2 = 0.37). However,
most of the variation was observed along coordinate 1, where
the viromes of urine, saliva, and feces shared similarities. CSF,
plasma, and body fluid specimens also clustered similarly on
coordinate 1. The breast milk specimens were located between
these separate clusters, and clustered separately from all other
specimen types along coordinate 3.
We also performed a permutation test to decipher whether
the differences observed by PCoA could be further supported
statistically (Table 1). We found that saliva and feces each could
be differentiated from other specimen types, but that there were
no statistically significant patterns amongst the other specimen
types. These data indicate that there are significant differences
amongst some specimen types, but most have shared features that
render them difficult to distinguish.
We measured alpha diversity in the viromes to discern
whether there were differences in the relative numbers of
virus genotypes and their distributions. We characterized alpha
diversity using the Homologous Virus Diversity Index (HVDI)
(Santiago-Rodriguez et al., 2015b) based on the chao1 index
(Chao, 1984), which takes into account the abundance of viruses
and their distribution, but also accounts for lesser abundant
viruses that may have been missed due to under sampling.
There was a significant (p < 0.001) contrast in the alpha
diversity observed in the viromes of urine, saliva, and feces when
compared to breast milk, body fluids, plasma, and CSF. Urine,
saliva, and feces were of relatively high diversity, while breast
milk, body fluids, plasma, and CSF were of relatively low diversity
(Figure 3). The alpha diversity found in viromes from the sterile
water controls was substantially lower than all the other viromes
from the various different body sites. We also examined the alpha
FIGURE 1 | Proportion of viral contigs with TBLASTX hits to the specified virus families. The y-axis represents the percentage of contigs homologous to each family,
or that were unclassified dsDNA phages or other viruses. The sample type is shown on the x-axis. The percentage of reads was determined based on the raw
number of reads used to assemble each contig.
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FIGURE 2 | Representation of beta-diversity based on Bray Curtis distances,
shown in Principal coordinates analysis of the viral communities. Ellipses are
drawn at 95% confidence intervals for sample type.
TABLE 1 | Viral homologs within and between specimen types.
By subject Percent homologous
within sample typea
Percent homologous
between sample typesa
P-valueb
CSF 17.38 ± 0.02 4.89 ± 0.07 0.0984
Body fluids 6.78 ± 0.03 5.32 ± 0.06 0.3878
Milk 17.00 ± 0.15 2.83 ± 0.06 0.1870
Plasma 11.20 ± 0.08 6.97 ± 0.09 0.3033
Stool 19.18 ± 0.12 2.00 ± 0.03 0.0382
Saliva 54.42 ± 0.05 1.76 ± 0.04 <0.0001
Urine 9.89 ± 0.08 1.77 ± 0.04 0.0925
aBased on the mean ± standard deviation of 10,000 iterations. 10,000 random
contigs were sampled per iteration; bP-value based on the fraction of times the
estimated percent homologous contigs within each sample type exceeds that for
different sample types. p-values <= 0.05 are represented in bold.
diversity using the Shannon index and found similar results, with
the exception that the fecal viromes had much lower diversity
(Supplementary Figure S9). These data indicate that there are
significant differences in the viral ecology of some body sites,
with breast milk, CSF, plasma and body fluids belonging to a low
diversity ecological cluster, and saliva, feces, and urine belonging
to a high diversity cluster.
Highly Homologous Viruses in CSF and
Other Specimen Types
We next examined whether there may be similar homologous
viruses within the ecological clusters. To examine these
similarities, we assembled contigs from all specimen types and
then measured the proportion of the resulting assemblies that
were derived from each specimen type. We found that the
majority of the contigs assembled from body fluids also included
contributions from CSF, breast milk, and plasma (Figure 4).
Few of the contigs assembled from body fluids included any
contributions from urine, saliva, or feces. A similar trend was
seen for CSF viromes that primarily assembled with body fluid,
plasma, and breast milk viromes; breast milk and plasma viromes
also followed this trend. A different trend was observed in feces,
saliva, and urine, where they primarily assembled with each
other. While the majority of the assemblies including saliva also
included feces and urine, a number of saliva assemblies also
included contributions from CSF, milk, and plasma. These results
help to solidify that the body surfaces can be grouped into two
separate clusters, one containing urine, feces, and saliva, and
another that includes CSF, plasma, body fluids, and breast milk.
We next characterized the homologous viruses shared between
specimen types to determine whether they were shared from a
single family or across multiple different families. We found that
there was no single virus family that was shared within or between
the different ecological clusters; instead, we found all observed
virus families shared across the specimen types (Figure 5). For
example, myoviruses, siphoviruses, and podoviruses, etc. were all
shared among feces, urine, and saliva, but each of these virus types
were also shared among breast milk, CSF, and body fluids. Very
little sharing was observed between the two separate ecological
clusters (Figure 5), with the exception of the aforementioned
sharing between CSF and saliva (Figure 4). Our results including
the sharing of homologous viruses, the grouping of viromes
according to their high or low relative alpha diversity, and the
clustering observed on the PCoA analysis, confirm the presence
of ecological clusters among viromes of different body sites and
demonstrate that the clusters are formed through the sharing of
viruses from multiple different families.
Individual Viruses
We characterized the structures of some of the shared
homologous viruses among the different body sites to
identify characteristics of some virus genomes that are shared
within ecological clusters. Viral genomes were constructed
by assembling contigs with high stringency among all of
the different body sites. We identified Contig1516 that was
assembled exclusively with contributions from urine, feces, and
saliva (Supplementary Figure S10). Interestingly, we did not
identify this virus in our prior study (Abeles et al., 2014), however,
we could identify the entire 56 kb viral genome from 7 of the 8
subjects in that study. While we could identify the entire structure
from saliva, we could only identify portions in 7 of the 9 fecal and
4 of the 20 urine viromes. This virus has significant homology to
other podoviruses similar to phi29. We also identified Contig20
that was identified in 4/6 body fluid specimens and in 20/20
CSF specimens (Supplementary Figure S11). This virus has
sequence similarities to other myoviruses, but has integrase
and repressor homologs, indicating that it likely has a primarily
lysogenic lifestyle. These data help to verify the existence of
shared membership among the viromes within the distinct
ecological clusters.
We also examined the CSF specimens to decipher whether
there were viruses present in the CSF of all subjects studied.
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FIGURE 3 | Homologous Virus Diversity Index rarefactions based on the Chao1 Index of viral communities from various specimen types. The x-axis represents the
number of virome reads sampled, and the y-axis represents virus abundance.
FIGURE 4 | Percentage of contigs that were used in the assembly of larger viruses from various human specimens. The y-axis represents the percentage of viruses
assembled that contained contigs from various specimen types, and the x-axis represents each specimen type. For example approximately 45% of viruses
assembled from body fluid viromes also contained contigs from cerebrospinal fluid.
We created assemblies from the contigs of all study subjects
using highly stringent criteria and examined those assemblies
to decipher which study subjects contributed to each virus
assembly. Of the 2429 CSF assemblies created, we found only
2 virus assemblies (0.08%) that were derived from all 20
subjects (Supplementary Figures S12A,B). The majority of the
assemblies created (74.1%) were derived from 1 or 2 subjects,
with only 1.1% of the assemblies derived from 10 or more
subjects. One of the two viruses that were assembled from
all 20 subjects include a putative 66.4 kb Myovirus that has
restriction/modification enzymes and includes a site-specific
integrase suggesting it has a lysogenic lifestyle (Figure 6A). The
other includes a putative 37.0 kb Siphovirus that has a transposase
that also suggests it has a lysogenic lifestyle (Figure 6B). Of
the 27 virus assemblies created from 10 or more subjects, 13
(48.1%) had genes, including transposases/integrases/repressors
that suggested lysogenic lifestyles. We could not identify the
bacteria hosts of the viruses we assembled.
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FIGURE 5 | Putative virus family assignments of contigs assembled from various human specimen types. The y-axis represents the raw number of contigs
assembled assigned to each virus family, and the x-axis represents contigs assembled from specific viromes.
Ion Torrent vs. Illumina Sequencing
We noted that the specimens belonging to each ecological
cluster seemed to correlate with sequencing modality, where
the urine, feces, and saliva cluster were all sequenced by
semiconductor sequencing (Rothberg et al., 2011), while the
plasma, CSF, body fluid, and milk cluster were all sequenced
with Illumina technology (Bentley et al., 2008). To verify that
sequence modality was not responsible for the ecological clusters,
we sequenced the CSF specimens using both semiconductor
and Illumina sequence technology and compared results.
We characterized the alpha diversity present in these CSF
specimens sequenced via semiconductor sequencing to decipher
whether there were substantial differences observed based
on the sequencing modality. The CSF specimens sequenced
via semiconductor sequencing generally had slightly higher
alpha diversity than was observed in these same specimens
sequenced using Illumina, but remained in the same ecological
cluster (Supplementary Figure S13). We also examined beta
diversity via PCoA and tested significance using a pairwise
Adonis test. Here, we found that the CSF specimens were
not significantly different based on the sequencing modality
used (Supplementary Figure S14). These data indicate that
sequencing method was not responsible for the ecological
clusters observed.
DISCUSSION
Prevailing clinical dogma suggests that the CNS and some
other surfaces are generally sterile in healthy individuals. Here
we prove otherwise using culture-independent methods to
assess the microbial constituents of CSF samples to reveal
a pervasive virome that appears to be partially shared with
plasma, body fluids, and breast milk. Our discovery of a CSF
virome suggests that the CNS is colonized by a somewhat
diverse viral community and challenges the clinical dogma that
the CNS is free of microbes in healthy individuals. While
herpesviruses have been known for some time to inhabit
the CNS of symptomatic individuals (Meyding-Lamade and
Strank, 2012), the majority of viruses that could be identified
were bacteriophages (Supplementary Figure S8). These phages
could merely be bystanders that have arrived in the CSF
without any clear role, but they could serve a more functional
role as non-host-derived immunity against potential bacterial
invaders, as has been hypothesized by others (Dabrowska
et al., 2005; Duerkop and Hooper, 2013; Barr, 2017; Nguyen
et al., 2017). Currently, there is limited evidence on whether
these viral communities play any functional role in the
CNS, but their discovery here obviates the need for further
study in this field.
We recognize that contamination is of significant concern
in identifying a virome present in a body site that previously
was believed to be devoid of viruses in healthy people. The
primary sources of any potential contamination in CSF samples
would likely be derived from the skin, blood, or consumables
used in the production of the viromes. We do not believe that
the skin is a reasonable source of contamination because of the
means by which the CSF is collected. The skin is first sterilized,
and then a single puncture with a needle is used to collect the
CSF. Because we examined the viromes only from Tube#3 (see
Materials and Methods section for further details), it is highly
unlikely that there could be sufficient remaining skin-derived
viruses present from a single skin puncture after 4–8 mL of CSF
have already been collected. Often, there is some blood in CSF
specimens because blood vessels can sometimes be punctured
as CSF is collected. However, for 7/20 of the subjects in this
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FIGURE 6 | Diagram of Contigs 76 (A) and 137 (B) assembled from CSF viromes of all 20 subjects. Putative ORFs and their direction are indicated by the arrow
boxes. ORFs that had significant homologs (BLASTX E < 10−5) are shown in blue, hypothetical proteins with unknown function are shown in yellow, and ORFs with
no known homologies are shown in gray.
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study, no blood was detected in their CSF (Supplementary
Table S1). We noted no differences in the virome diversity or
contents based on whether there were RBCs detected in the
CSF. We tested water that had been taken through the exact
same extraction process as the CSF to determine whether the
presence of viruses could have been derived from the virome
extraction process. While we could find viruses in the virome
extracted sterile water, they were not the same viruses we
observed in the CSF viromes, nor did these viromes have similar
diversity (Figure 3).
We characterized the viromes of 7 different body surfaces
and revealed two separate viral ecological groups dominated
by phages with varying properties: a high diversity viral group
that included feces, saliva, and urine, and a low diversity
group made up of CSF, body fluids, plasma, and breast milk.
The robust and diverse bacterial communities inhabiting feces,
saliva, and urine might explain why these sample sites had
high virome diversity. The low diversity viral group, including
CSF, body fluids, and plasma, generally had few if any bacterial
communities associated, which likely explains why few VLPs
were observed and the low diversity. Interestingly, breast milk
was associated with the low diversity cluster, but is also known
to harbor relatively diverse bacterial communities (Hunt et al.,
2011; Pannaraj et al., 2017), so the ecological clustering of the
specimen types cannot be explained merely by the presence of
bacteria. The breast milk virome has unique features amongst the
specimens, including the predominance of myoviruses (Figure 1)
and the differences in beta diversity (Figure 2). In further
analysis of breast milk viromes, we note that these populations
are quite uneven, with the majority of the breast milk virome
sequence reads belonging to just a few viruses. For example,
the most abundant virus in the breast milk viromes represented
27.8 ± 2.3% of the virome reads, and the top two viruses
represented 41.9 ± 3.5% of the reads. This uneven population
likely contributed substantially to the low virome diversity
of the breast milk specimens compared to the high virome
diversity observed in other specimen types where bacterial
diversity was relatively high. We observed a similar phenomenon
when examining alpha diversity in the feces using the Shannon
Index compared to the Chao1 index (Supplementary Figure S9
and Figure 3). The lower alpha diversity measured using the
Shannon index likely was due the fact that the Shannon index
does not account for the many low abundance viruses found
in the gut. Because the viromes in this study were MDA
amplified, biases could have been introduced that affected alpha
diversity, however, we did not identify such biases in our prior
study where we validated the methodology (Santiago-Rodriguez
et al., 2015b). Additionally, MDA amplification may introduce
biases when examining differential abundances of the viruses
present (Roux et al., 2016). It is important to note that for
most analyses in this study we assign reads to virus contigs,
but the abundances we evaluate are based on the number
of these different virus contigs, not the proportion of reads
assigned to the contigs.
There are a number of limitations to the methods we used to
isolate and sequence viruses that have been revealed in a series
of recent studies (Hunt et al., 2011; De Vlaminck et al., 2013;
Shah et al., 2014; Wylie et al., 2014, 2015; Briese et al.,
2015; Conceicao-Neto et al., 2015; Kleiner et al., 2015; Roux
et al., 2016). Those methods include sequential filtration and
Cesium chloride density gradient centrifugation. We still chose
to isolate and sequence these viromes using these existing
techniques so that they could be directly compared to our
substantial existing library of specimens sequenced using
the same techniques. By keeping the methodology constant
for all 7 specimen types used, we reduced biases between
studies that arise by altering the virus processing protocols,
and the consistency of our study protocols allowed us to
establish the ecological clusters. Despite these benefits, the
limitations of the protocols include, underrepresentation of
eukaryotic and enveloped viruses, no accounting for RNA
viruses, overrepresentation of small single stranded DNA
viruses (although this has not been apparent in our studies),
inability to perform quantitative analysis, filtering out larger
viruses, and underrepresentation of smaller viruses due to
density gradient methods. Membership of CSF viromes may
differ from this study if other existing virome processing
methodologies are used.
Identifying the source of the CSF virome is of substantial
importance. Prior to performing this study, we hypothesized
that the GI tract would be the primary source of viromes
throughout the body due to transcytosis of viruses across the
gut epithelium into the bloodstream (Nguyen et al., 2017),
where those viruses may then be distributed to the tissues
and body fluids. Thus, body sites that are relatively devoid
of bacteria would have their viromes established from the GI
tract. We expected that CSF, body fluid, plasma, and perhaps
even breast milk viromes would all have significant similarity
to each other and contain viral types originating from the GI
tract. Our data did suggest that CSF, body fluid, plasma and
to an extent breast milk, all contained similar, low diversity
viromes, but we could not establish a strong connection between
these viromes and the GI tract. Instead, we identified greater
similarity between CSF and salivary viromes than we did for fecal
viromes (Figure 4). It is an intriguing possibility that on some
body surfaces with few if any bacteria, transcytosis may allow
viruses to access these compartments via the bloodstream. We
hypothesized that the GI tract was a primary source of these
viruses due to its large surface area, however, the oral cavity
contains a large surface area and could provide the primary
source for the low diversity virome seen in CSF samples (Collins
and Dawes, 1987). We did not identify any strong evidence
of the source of these viruses by examining the structures of
the viruses that were present in multiple different subjects, but
did find evidence that many of them had temperate lifestyles
(Figure 6). Further studies are required to establish whether
viruses may transcytose across oral mucosal layers and seed
other body surfaces.
While we identified viruses in the CSF of this study
population, we were not able to ascertain whether they were
stable members of the CSF virome. Because this study was
not longitudinal, we do not know whether the viruses we
observed would be the same viruses we could identify if we
examined the CSF virome of these same individuals days, weeks,
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or even months later. The invasive nature of obtaining CSF
via lumbar puncture prohibited us from performing such an
analysis. We believe that many of the bacteriophages found
in the CSF arrived into the CNS via transcytosis and do not
have viable host cells they are capable of infecting in the
CSF. Thus, many of these viruses likely are transient members
of the CSF virome.
The discovery of a virome in the CSF and various body
fluids suggests that there are no body surfaces that are free
of microbes. To date, viromes have been identified in saliva,
dental plaque, feces, skin surfaces, breast milk, urine, lungs,
blood, the vagina, and now body fluids and CSF. While the
contents of viromes may appear different based on the techniques
used to characterize them, each of the viromes detailed in this
study were characterized using the same methodology. This
methodology reveals taxonomic differences amongst viromes,
including an abundance of microviruses in the feces, siphoviruses
in the mouth, and myoviruses in breast milk. The most striking
feature amongst the viromes was the high and low diversity
ecological clusters identified, where body surfaces with many
bacteria generally had high virome diversity, while others such
as CSF and body fluids had low diversity. Even in the CSF
and body fluid of infected individuals, there was low virome
diversity. Thus, differences in alpha diversity appear to be features
of each body surface. Further study is necessary to determine
the origin of the viruses on many of these surfaces and to
decipher why certain surfaces have low viral diversity compared
to their counterparts.
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FIGURE S1 | Epifluorescence microscopy of Virus-Like Particles (VLPs) present in
the CSF (A) or in saliva for comparison (B).
FIGURE S2 | Size distribution of the contigs for body fluid and cerebrospinal fluid
samples. Contig length is shown on the y-axis and the sample ID is shown on the
x-axis. The break in the y-axis represents a change in the scale of axis intervals.
FIGURE S3 | Percentages of virome reads (± standard error) belonging to contigs
with significant sequence similarities within the NCBI NR database. The
percentage of reads was determined based on the raw number of reads used to
assemble each contig. The percentage of reads is shown on the y-axis, and the
category of BLASTX homolog is shown on the x-axis.
FIGURE S4 | Percentages of contigs with significant sequence similarities within
the IMG/VR v2.0 database. Contigs with significant homologs in the database are
shown in black and those with no significant homologs are shown in gray. The
percentage of contigs is shown on the y-axis and the specimen type and number
is shown on the x-axis.
FIGURE S5 | Percentages of contigs with BLASTX homologs in the IMG/VR v2.0
database and the associated environments from which top homologs were
derived. The percentage of contigs is shown on the y-axis and the specimen type
and number is shown on the x-axis.
FIGURE S6 | Representation of beta-diversity based on Bray Curtis distances,
shown in Principal coordinates analysis of body fluids and cerebrospinal fluid. CSF
specimens are represented by blue circles and body fluid specimens are
represented by red circles. Ellipses are drawn at 95% confidence intervals
for sample type.
FIGURE S7 | Percentages of contigs (± standard error) with significant sequence
similarities using TBLASTX analysis of the virus database at NCBI. The percentage
of contigs is shown on the y-axis and the specimen type is shown on the x-axis.
FIGURE S8 | Proportion of viral contigs with TBLASTX hits to the specified virus
families. The y-axis represents the percentage of reads belonging to contigs
homologous to each family, or that were unclassified dsDNA phages or other
viruses. Fluid and CSF from subjects with known infections is
demonstrated above the bars.
FIGURE S9 | Homologous Virus Diversity Index rarefactions based on the
Shannon Index of viral communities from various specimen types. The x-axis
represents the number of virome reads sampled, and the y-axis represents
virus abundance.
FIGURE S10 | Diagram of contig 1516 assembled from saliva, stool, and urine
viromes. The portions of the contig that were represented in the saliva of eight
different subjects, in the stool of seven different subjects, and in the urine of four
different subjects are shown below. Putative ORFs and their direction are indicated
by the arrows at the top of the diagram. ORFs that had significant homologs
(BLASTX E-score < 10−5) are indicated by the text above each arrow.
FIGURE S11 | Diagram of contig 20 assembled from body fluid and CSF viromes.
The portions of the contig that were represented in the body fluids of five different
subjects and in the CSF of 20 different subjects are shown below. Putative ORFs
and their direction are indicated by the arrows at the top of the diagram. ORFs
that had significant homologs (BLASTX E-score < 10−5) are indicated by the text
above each arrow.
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FIGURE S12 | Bar graphs representing the number of subjects that contributed to
each assembled CSF contig (A) and the percentage of contigs constructed from
the different numbers of subjects (B). The x-axis represents the number of
different subjects and the y-axis represents the number of contigs or the
percentage of contigs constructed.
FIGURE S13 | Homologous Virus Diversity Index rarefactions based on the Chao1
Index of viral communities from various specimen types. The x-axis represents the
number of virome reads sampled, and the y-axis represents homologous diversity.
The CSF specimens sequenced using semiconductor sequencing (yellow circles)
had higher diversity than those sequenced by Illumina (white circles), but remained
in the low diversity cluster.
FIGURE S14 | Representation of beta-diversity based on Bray Curtis distances,
shown in Principal coordinates analysis of the viral communities. The CSF
specimens sequenced using semiconductor sequencing (pink circles) clustered
similarly to those sequenced by Illumina (blue circles). Ellipses are drawn at 95%
confidence intervals for sample type.
TABLE S1 | Characteristics of study subjects/specimens.
TABLE S2 | Contig metrics from study specimens.
TABLE S3 | Contig metrics from CSF specimens.
TABLE S4 | IMG/VR BLASTX homolog habitats.
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